ZTABS builds RAG systems for Boston enterprises working with complex document corpora in healthcare, legal services, financial services and research. Boston's concentration of academic medical centres generates clinical evidence corpora requiring precise retrieval. Legal firms need research systems with citation accuracy. Financial services firms face regulatory complexity across SEC, FINRA and state requirements. ZTABS is remote-first by design from our Houston, Texas office.
RAG development in Boston at a glance
| Need | What we build | Key requirement |
|---|
| Clinical evidence | Guidelines and literature retrieval | FDA CDS intended function assessment |
| Legal research | Case law and regulatory search | Licensed source access and pinpoint citation |
| Financial compliance | Regulatory and policy search | Multi-authority coverage |
| Research | Publication and data retrieval | De-identification compliance |
| Higher education | Campus knowledge and admissions | Slate CRM and API licensing |
Clinical evidence retrieval
Boston's healthcare ecosystem requires RAG systems that handle clinical evidence with regulatory awareness.
Clinical guideline retrieval. Current clinical practice guidelines from specialty organisations retrievable with evidence grade citations. Queries return guideline-based information with specific citations, evidence quality indicators and publication dates. Systematic review evidence distinguishable from expert consensus recommendations. RAG provides retrieval assistance; approved clinical professional review of retrieved content is required before patient care decisions. Source access rights for guideline databases and journal subscriptions confirmed per provider.
Drug information retrieval. Drug monographs, interaction databases, prescribing information and clinical trial results searchable by drug name, class, indication, interaction pair and patient population. Dose adjustment context for renal, hepatic and paediatric populations with specific prescribing information citations. Retrieval and user interface languages tested against actual clinical audience tasks.
FDA CDS scope. FDA final 29 January 2026 CDS guidance supersedes the 6 January version. Non-device CDS status requires meeting all four statutory criteria, including that the healthcare professional can independently review the basis for the recommendation. A RAG or retrieval architecture label alone does not determine regulatory status; the intended function determines classification. February 2026 CSA guidance concerns software used in device production and QMS, not a general test of whether clinical RAG is a medical device.
Clinical trial evidence. Published trial results, protocol summaries and systematic reviews indexed for evidence synthesis. Preparatory research is limited to representations and necessary PHI review without removal from the covered entity; workforce researchers may contact prospective subjects under actual authorised basis, while outside researchers cannot use the preparatory provision alone to contact subjects and may need partial IRB or Privacy Board waiver or other valid authorisation.
Building a RAG system for your Boston clinical operations?
Tell us about your clinical document corpus, evidence sources and regulatory scope. We start with a data audit to identify the highest-value retrieval use case.
Legal research systems
Boston's legal sector requires RAG with precise citation handling across multiple authorities.
Case law retrieval. Federal and Massachusetts case law indexed with metadata for court, date, topic and procedural posture. Queries return relevant case analysis with pinpoint citations to specific pages, paragraphs or sections. Cross-citation resolution links related authorities. Licensed citator access (Shepard's, KeyCite or equivalent) supports current controlling authority and adverse treatment verification; attorney review confirms applicability.
Statutory and regulatory search. Federal and state statutes, regulations, agency guidance and enforcement actions searchable by topic, jurisdiction, agency and effective date. Legislative history retrieval for statutory interpretation. Regulatory change monitoring surfaces new rules relevant to practice areas.
Firm knowledge management. Internal memos, research notes, brief banks and practice group knowledge indexed with matter-level access controls. Institutional knowledge preservation as attorneys transition roles. Matter-level and client-level access policies tested and enforced; policy controls and periodic review reduce information barrier risk.
Contract and transaction knowledge. Clause libraries, executed agreement precedents and negotiation notes searchable by clause type, deal structure and counterparty. Version comparison across contract iterations. Deal experience retrieval for pitch preparation.
Financial compliance retrieval
Boston financial services firms need regulatory knowledge retrieval across multiple authorities.
SEC and FINRA compliance. SEC rules, no-action letters, enforcement actions and FINRA regulatory notices searchable by topic, rule number, date and affected activity. Compliance monitoring surfaces new regulatory requirements. Internal compliance policies linked to specific regulatory requirements.
Investment research knowledge. Analyst reports, research notes, investment committee presentations and due diligence materials indexed with access controls. Research retrieval supports investment decision-making with documented evidence trail.
Risk and compliance documentation. Risk policies, compliance procedures, audit findings and regulatory examination responses searchable by risk domain, regulation and business unit. Institutional knowledge preservation for compliance staff continuity.
Regulatory examination preparation. Prior examination responses, regulatory correspondence and remediation documentation retrievable for examination preparation. Historical regulatory interaction patterns support examination strategy.
Research and biotech documentation
Boston's research institutions and biotech companies need specialised document retrieval.
Publication retrieval. Journal articles, preprints, conference proceedings and internal research notes indexed with full text, abstracts, citation networks and subject metadata with source access rights confirmed per publisher subscription. Queries return relevant publications with specific section citations. Citation network traversal connects related research threads.
Patent search. Patent databases indexed for prior art, freedom-to-operate and competitive intelligence. Claims-level indexing for precise technical concept retrieval. Patent family linkage across jurisdictions.
Laboratory documentation. Lab notebooks, experiment protocols, equipment qualification records and analytical method documentation searchable by project, technique and instrument. Version-aware retrieval ensures current protocol references.
EHR and campus system integration. Epic, Cerner and laboratory information system APIs require actual licence and object rights per vendor. HIPAA Business Associate agreements are required for separate entities performing functions involving PHI on behalf of a covered entity; internal workforce access operates under the entity's own workforce access policies. Slate is a higher-education CRM for admissions, student engagement and advancement, not a clinical EHR or lab research system; campus integrations with Slate operate under Slate's actual API permissions and data access terms in the correct category.
Higher education and research institutions
Boston's research universities need RAG for institutional knowledge.
Research administration. Grant documentation, institutional review board records, research compliance requirements and intellectual property documentation indexed for research administration staff. Grant lifecycle retrieval from submission through reporting.
Academic knowledge management. Course materials, curriculum documentation, accreditation records and faculty research profiles indexed for academic and administrative staff. Cross-departmental knowledge retrieval supports interdisciplinary research collaboration. Accreditation preparation supported by evidence retrieval across institutional documentation.
201 CMR 17 and regulatory compliance
201 CMR 17 scope. Massachusetts data protection regulation defines personal information and applies to entities that own or licence personal information of Massachusetts residents. Actual owns-or-licences roles determine compliance obligations. A written information security programme (WISP) is required. Encryption is required for personal information transmitted over public networks and stored on portable devices where technically feasible. Access controls limit personal information access to those with legitimate business need.
HIPAA compliance. HIPAA applies to health plans, healthcare clearinghouses and healthcare providers that transmit information in connection with covered standard electronic transactions. Business Associate agreements define PHI handling responsibilities for separate entities performing functions involving PHI on behalf of a covered entity or another BA. Minimum necessary applies where applicable; treatment disclosures to and requests by healthcare providers are excepted, as are disclosures pursuant to individual authorisation. For internal use, covered entities implement role-based workforce access policies identifying persons or classes, PHI categories and access conditions; broad internal access requires explicit justified policy. Local deployment on HIPAA-eligible infrastructure with encryption, access controls and audit logging addresses PHI requirements; embedding and generation configured without external API calls for PHI, with support access, telemetry, log shipping and backup terms reviewed per component.
HHS Safe Harbor. HIPAA Safe Harbor de-identification requires removing all 18 categories of prescribed identifiers of individuals and their relatives, employers and household members across structured and free text. The covered entity must also have no actual knowledge that remaining information could identify an individual alone or combined with other information. Expert determination is a separate route with residual re-identification risk assessed by a qualified statistical or scientific expert. Neither route achieves zero re-identification risk.
Source ingestion and retrieval architecture
Ingestion provenance. Every document tracked from source through parsing, chunking and embedding. Version control ensures retrieval reflects current document versions. Source retirement removes superseded content. Clinical guideline version tracking ensures current recommendations with effective version confirmed through issuing body.
Format extraction and limitations. Well-structured native digital documents generally extract text reliably; scanned legal documents and older biotech patents require extraction testing on representative samples. Complex tables, clinical trial results tables and chemical structures have inherent extraction limitations. Table extraction preserves structure for standard formats.
Chunking strategy. Clinical guidelines chunked by recommendation level with evidence grade preservation. Legal documents chunked by paragraph with citation preservation. Financial regulations chunked by section with cross-reference linkage.
Hybrid search. BM25 for exact terms (case citations, drug names, statute sections, gene names) combined with semantic search for conceptual queries. Reranking with cross-encoder models improves result quality. Source citations reference specific document sections; citation presence alone does not guarantee answer correctness.
Security and access control
PHI protection. Local deployment on HIPAA-eligible infrastructure for clinical data with encryption, access controls and audit logging. Minimum necessary where applicable. Embedding and generation configured without external API calls for PHI; support access, logs, backups and provider terms reviewed per component.
Matter-level isolation. Legal document access restricted by matter, client and privilege status. Information barrier enforcement through tested policy controls and periodic access review; no technical control eliminates leakage risk entirely.
Prompt injection defence. Retrieved documents can contain adversarial content. Retrieved text is evidence for answer generation, not permission or executable instructions. Input sanitisation, output filtering and result isolation reduce but do not eliminate injection risk.
Evaluation and quality
Held-out real task evaluation. Quality measured on representative held-out tasks from actual users. Clinical evaluation includes guideline queries and drug information searches. Legal evaluation includes case research queries and statutory analysis. Financial evaluation includes regulatory compliance questions. Justified adversarial and edge-case tests complement real-task evaluation. Measured results reported to the client.
Citation and answer quality. A cited source does not guarantee the generated answer is correct, complete or calibrated. Legal citation accuracy is critical as nonexistent case citations create professional liability. Licensed citator verification checks cited authorities exist and support generated claims; attorney review confirms current controlling status.
Illustrative Example
Hypothetical: Boston academic medical centre building clinical evidence RAG
A Boston academic medical centre with 1,200 attending physicians across 28 departments has clinical evidence scattered across multiple sources: 15,000 clinical practice guidelines from specialty organisations, 42,000 journal articles in the institutional library, hospital-specific protocols and order sets in the EHR and drug information databases across 3 subscribed resources.
RAG development would implement multi-source ingestion across guideline databases, journal article repositories, EHR protocol systems and drug information resources with source access rights confirmed per publisher and vendor. Evidence-grade-aware chunking preserving recommendation levels and citation contexts. Hybrid retrieval combining exact drug name and guideline identifier matching with semantic clinical concept search. Evidence quality filtering allowing clinicians to prioritise systematic review evidence over expert consensus. HIPAA BA agreements for each separate entity performing functions involving PHI on behalf of the covered entity.
Assumptions: guideline databases support structured export under actual subscription terms, journal article full text available through institutional subscriptions, EHR protocol APIs accessible under actual vendor licence terms, drug information APIs available for ingestion, and clinical subject matter experts available for evaluation dataset creation (300 to 500 clinical questions with expected evidence sources). Local deployment on HIPAA-eligible infrastructure with encryption, access controls and audit logging; embedding and generation configured without external API calls for PHI, with support access, telemetry, log shipping and backup terms reviewed per component. Residual risks include guideline update frequency requiring regular re-ingestion, evidence grading inconsistency across organisations, clinical terminology variation across specialties, FDA 29 January 2026 CDS intended function assessment determining regulatory scope, ACL synchronisation latency and adoption requiring integration with existing clinical workflows. Approved clinical professional review of retrieved evidence before patient care decisions.
This is a hypothetical scenario for illustration. Actual scope, timeline and cost depend on your requirements.
Cost and timeline
RAG system development follows the published cost guide.
| Tier | Range | Timeline | Example |
|---|
| Basic / MVP | $15K to $40K | 4 to 8 weeks | Simple document Q&A |
| Mid-Range | $40K to $100K | 8 to 18 weeks | Hybrid search with citations |
| Advanced | $100K to $150K | 18 to 28 weeks | Multi-index clinical evaluation |
| Enterprise | $150K to $200K+ | 5 to 8 months | Multi-tenant HIPAA-compliant |
Proposal evaluation criteria
Six criteria for evaluating any RAG system proposal for Boston operations.
| Criterion | What to verify |
|---|
| Source rights, licences and data-flow mapping | Licensed access for guideline databases, journal subscriptions, EHR APIs and citator services; full-stack data flows including embedding service, generation API, logs, telemetry, backups and subprocessor locations |
| Tested permissions, revocation and downstream controls | Per-tenant, per-matter and per-source ACLs with tested information barrier policy controls, HIPAA minimum necessary where applicable with treatment-disclosure and individual-authorisation exceptions plus role-based workforce access policies, revocation propagation latency measured, and any authorised downstream actions explicitly scoped |
| Held-out tasks, citation checks, abstention and acceptance | Representative held-out clinical and legal research tasks with measured precision, recall, MRR and latency; justified adversarial and edge-case tests; abstention policy for insufficient evidence; citation verification against licensed authority databases; agreed acceptance thresholds |
| Scope, milestones and operating-cost assumptions | Complete delivery scope with milestones, workload assumptions, and indicative monthly vector-database ($25 to $1,000) and LLM generation ($200 to $5,000) cost ranges qualified by query volume, context window, token pricing, hosting model and plan tier |
| Ingestion lifecycle, recovery, monitoring and ownership | Version-aware ingestion with guideline and regulation change tracking, superseded-document retirement, sync latency, backup and restore, incident response, monitoring dashboards and data ownership terms |
| Customer and provider responsibilities, languages and training | Operating runbook, recovery drills, support tiers, customer-retained approved clinical professional and attorney review, on-site roles agreed before commitment, and user interface, documentation and delivery languages agreed per engagement |
2026 US-buyer planning benchmark. A production RAG system over approximately 10,000 documents with multiple document formats and ingestion pipelines, hybrid retrieval and reranking, source citations, authentication and role-based access, admin and evaluation workflows, content and licensing rights management, and full-stack operating infrastructure typically falls within the Mid-Range to Advanced tier at $40K to $150K over 8 to 28 weeks. Indicative recurring costs include vector-database hosting at $25 to $1,000 per month and LLM generation at $200 to $5,000 per month, qualified by actual query volume, context window size, token pricing, hosting model and plan tier. These are published guide ranges for scoping, not project-specific quotes, and exclude customer-side licensing, infrastructure and domain-expert review costs.
Budget look right for your Boston RAG project?
Share your document corpus size, clinical scope and compliance requirements. We provide a scoped estimate based on actual retrieval complexity.
How delivery works
ZTABS is remote-first by design from our Houston, Texas office.
Architecture. Data audit covering document formats, volumes, access patterns and quality. Architecture decisions on embedding model, vector database, search pipeline and deployment. Component-level data-flow mapping for each service handling PHI or privileged legal content.
Data pipeline. Multi-format ingestion with domain-specific parsers for clinical guidelines, legal documents and financial regulations. Document-aware chunking preserving evidence grades and citation contexts. Metadata enrichment with document type, evidence level, jurisdiction, date and regulatory reference.
Deployment. Local deployment on HIPAA-eligible infrastructure for clinical data with encryption, access controls and audit logging. Containerised deployment with CI/CD pipeline. Access control enforcement at infrastructure level for PHI and privileged legal content.
Monitoring. Query logging with response quality tracking. Retrieval performance metrics per document type. Ingestion pipeline health monitoring. PHI access audit logging.
Full stack considerations
Model provider terms affect data governance for clinical and legal data. Local models keep PHI inside the boundary when configured without outbound calls; support access, telemetry, log shipping and backup terms assessed per component. Vector database hosting scales with document count ($25 to $1,000 per month). LLM generation costs range from $200 to $5,000 per month depending on query volume and context window size. Indexes, logs, backups, SDKs, support contracts and subprocessors are part of operational scope requiring assessment.
When ZTABS is not the right fit
- Corpus under 50 documents. Standard search handles this more cost-effectively.
- Off-the-shelf platform covers the need. Use existing tools first.
- On-site embedded staff required. ZTABS is remote-first by design. Where this engagement requires on-site roles, languages or responsibilities, agree these before commitment or engage a separate provider.
- Work principally requiring clinical practice or medical advisory. Where the engagement scope is principally clinical practice, medical advisory or healthcare compliance determination rather than scoped RAG delivery, the customer retains appropriately qualified clinical professionals; who handles validation, training and support agreed before commitment.
- Work principally requiring legal advice or attorney services. Where the engagement scope is principally legal advisory, regulatory interpretation or attorney work rather than scoped RAG delivery, the customer retains qualified counsel; responsibilities agreed before commitment.
Risks and mitigations
Clinical hallucination. RAG reduces but does not eliminate hallucination in clinical contexts. A valid citation does not guarantee clinical accuracy. Evaluation pipelines and approved clinical professional review remain essential for patient safety.
Legal citation accuracy. Nonexistent case citations create professional liability. Licensed citator verification against authority databases checks that cited cases exist and support generated claims; attorney review confirms current controlling status.
HIPAA BA chain. Each separate entity performing functions involving PHI on behalf of a covered entity or another BA requires a Business Associate agreement with appropriate security and breach notification terms. Local components reduce the number of external parties handling PHI. Support access, log shipping and backup replication reviewed per component.
FDA regulatory scope. Clinical RAG intended function assessment under 29 January 2026 CDS guidance determines FDA regulatory classification. Non-device status requires all four statutory criteria. Architecture documents intended function and information flow for regulatory analysis.
Ready to build your Boston RAG system?
Share your document types, regulatory landscape and retrieval priorities. We scope the architecture and identify the highest-value corpus to pilot.